VANCOMYCIN HYDROCHLORIDE FOR INJECTION 1 G — DIN 02396386
VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE) : 1 G · STERIMAX INC · POWDER FOR SOLUTION · wholesale supply in Canada
Health Canada status: DORMANT
What is VANCOMYCIN HYDROCHLORIDE FOR INJECTION?
VANCOMYCIN HYDROCHLORIDE FOR INJECTION 1 G contains VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE) : 1 G. It is listed in the Health Canada Drug Product Database under DIN 02396386, held by STERIMAX INC, supplied as POWDER FOR SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as dormant, status dated 31-Jul-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
What is VANCOMYCIN HYDROCHLORIDE FOR INJECTION used for?
Vancomycin Hydrochloride for Injection, administered intravenously, is indicated for the treatment of severe or life-threatening staphylococcal infections in patients who cannot receive or have failed to respond to the penicillins or cephalosporins or who have infections with staphylococci resistant to other antibiotics, including methicillin. Vancomycin alone has been used effectively in the treatment of staphylococcal endocarditis. Vancomycin has also been reported to be effective alone or in combination with an aminoglycoside for treatment of endocarditis, caused by S. viridans or S. bovis. For endocarditis caused by enterococci (S. faecalis), vancomycin has been reported to be effective only in combination with an aminoglycoside. Vancomycin has been reported to be effective for the treatment of diphtheroid endocarditis. It has been used successfully in combination with either rifampin, an aminoglycoside, or both, in early-onset prosthetic valve endocarditis caused by S. epidermidis or diphtheroids. The effectiveness of vancomycin has been documented in other infections due to staphylococci, including osteomyelitis, pneumonia, septicemia and soft-tissue infections. Antibiotics are used as adjuncts to appropriate surgical measures when staphylococcal infections are localized and purulent. Specimens for bacteriologic cultures should be obtained in order to isolate and identify causative organisms and to determine their susceptibilities to vancomycin. Although no controlled clinical efficacy trials have been conducted, intravenous vancomycin has been suggested by the American Heart Association and the American Dental Association as prophylaxis against bacterial endocarditis in patients who are at risk in the following situations: a) In Dental, Oral or Upper Respiratory Tract Procedures As an alternate prophylactic regime in ampicillin/amoxicillin/penicillin-allergic patients considered high risk. b) In Genitourinary and Gastrointestinal Procedures In combination with gentamycin in ampicillin/amoxicillin/penicillin-allergic patients. The parenteral form of vancomycin may be administered orally for the treatment of staphylococcal enterocolitis and antibiotic-associated pseudomembranous colitis produced by Clostridium difficile.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Is there a generic Vancomycin in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
16 holders have a Canadian DIN containing Vancomycin, across 59 DINs, of which 22 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| STERIMAX INC | 7 | 4 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | Sourceable in Canada |
| FRESENIUS KABI CANADA LTD | 6 | 4 | VANCOMYCIN HYDROCHLORIDE CAPSULES, USP, VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Sourceable in Canada |
| MARCAN PHARMACEUTICALS INC | 4 | 3 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 4 | 3 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Sourceable in Canada |
| HIKMA CANADA LIMITED | 4 | 2 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Sourceable in Canada |
| EUGIA PHARMA INC. | 3 | 2 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Sourceable in Canada |
| GENERIC MEDICAL PARTNERS INC | 2 | 2 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 6 | 1 | JAMP-VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Sourceable in Canada |
| BAXTER CORPORATION | 2 | 1 | VANCOMYCIN INJECTION USP IN 0.9% SODIUM CHLORIDE, VANCOMYCIN INJECTION USP IN 5% DEXTROSE | Sourceable in Canada |
| MYLAN PHARMACEUTICALS ULC | 4 | 0 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | No marketed DIN |
| PFIZER CANADA ULC | 4 | 0 | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | No marketed DIN |
| LYPHOMED, DIVISION OF FUJISAWA CANADA INC. | 3 | 0 | STERILE VANCOMYCIN HCL 5.0GM/VIAL, STERILE VANCOMYCIN HCL USP 1.0GM/VIAL, STERILE VANCOMYCIN HCL USP 500MG/VIAL | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 1 G |
|---|---|
| Dosage form | POWDER FOR SOLUTION |
| Route | INTRAVENOUS |
| Pack configuration (monograph) | 500 mg vancomycin base in 10 or 20 mL single-dose glass vials, closed with rubber stoppers and flip-off caps. Packages of 10 (20 mL vials) or 25 (10 mL vials) |
| Storage | Dry Powder Vancomycin hydrochloride powder should be stored between 15° and 25ºC. Solutions Reconstituted solutions and further diluted infusion mixtures should be used within 24 hours if kept at room temperature or within 72 hours if stored under refrigeration (5°C). If prepared in a facility with a recognized parenteral intravenous admixture program, such mixtures may be kept up to 96 hours if stored under refrigeration (5°C). |
| Shipping class | Cold chain — validated shipper with temperature monitoring |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Cold chain. This product is stored refrigerated. Nexara ships it on a validated cold chain with temperature monitoring; a delivery address that cannot receive and store it at 2–8 °C on arrival must be flagged before the order is placed.
Substance and classification
| Active substance | Vancomycin |
|---|---|
| ATC code | J01XA01 |
| AHFS class | 08:12.28.16 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02396386 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2396386 |
| Brand name | VANCOMYCIN HYDROCHLORIDE FOR INJECTION |
| Generic / active ingredient | VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE) : 1 G |
| Market authorization holder | STERIMAX INC |
| Health Canada schedule | Prescription |
| ATC code | J01XA01 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J01XA |
| Current status | DORMANT |
| Status date | 31-Jul-2019 |
| Original market date | 2013-01-30 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
22 of 59 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | 500 MG | POWDER FOR SOLUTION | STERIMAX INC | MARKETED | 02342855 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | 5 G | POWDER FOR SOLUTION | STERIMAX INC | MARKETED | 02405822 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | 500 MG | POWDER FOR SOLUTION | GENERIC MEDICAL PARTNERS INC | MARKETED | 02435713 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | 1 G | POWDER FOR SOLUTION | GENERIC MEDICAL PARTNERS INC | MARKETED | 02435721 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | 10 G | POWDER FOR SOLUTION | STERIMAX INC | MARKETED | 02405830 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | 1 G | POWDER FOR SOLUTION | STERIMAX INC | MARKETED | 02342863 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500 MG | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | 02394626 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 5 G | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | 02394642 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500 MG | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | 02139375 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 5 G | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | 02139243 |
2 · Same class — other molecules in ATC J01XA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Vancomycin | JAMP-VANCOMYCIN · PMS-VANCOMYCIN 1 G · PMS-VANCOMYCIN 500 MG · STERILE VANCOMYCIN HCL 5.0GM/VIAL · +11 more | 59 | 22 | Yes |
| Dalbavancin | XYDALBA | 1 | 1 | Yes |
| Telavancin | VIBATIV | 2 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC J01X
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| J01XX | Bacitracin · Daptomycin · Fosfomycin · Lefamulin · Linezolid · +4 more | 52 | 15 |
| J01XE | Nitrofurantoin | 24 | 9 |
| J01XB | Colistin · Polymyxin B | 6 | 4 |
| J01XD | Metronidazole | 7 | 2 |
| J01XC | Fusidic Acid | 3 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is VANCOMYCIN HYDROCHLORIDE FOR INJECTION called?
The same molecule, Vancomycin, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| VANCOMYCIN HAMELN | Latin | Czechia |
| VANCOMYCIN MYLAN | Latin | Czechia |
| VANCOMYCIN VIATRIS | Latin | Czechia |
| VANCOMYCIN APTAPHARMA | Latin | Czechia |
| VANCOMYCIN OLIKLA | Latin | Czechia |
| VANCOMYCIN SANEXCEL | Latin | Czechia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
What is Vancomycin called in other languages?
Buyers, prescribers and procurement teams outside Canada often search for the ingredient in their own script. These are phonetic renderings of the ingredient name Vancomycin, published to help those searches reach this page.
| Language | Vancomycin |
|---|---|
| Spanish Español | Vancomicina |
| French Français | Vancomycine |
| Portuguese Português | Vancomicina |
| German Deutsch | Vancomycin |
| Korean 한국어 | 반코마이신 |
| Vietnamese Tiếng Việt | Vancomycin |
| Indonesian Bahasa Indonesia | Vancomycin |
These are transliterations of the ingredient name, generated automatically and published only where two independent checks agreed. They are not registered local trade names and carry no marketing authorisation in any market. Always confirm a product against its local registration before ordering.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.